Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Mitoxantrone, Thiotepa, and Cyclophosphamide with Amifostine in Breast Cancer
NCT00003068Phase 2Completed
- Sponsor
- University of Arizona
- Start
- Jun 1997
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of mitoxantrone, cyclophosphamide in breast cancer, sponsored by University of Arizona. Started Jun 1997; status: completed.
02
Drugs
mitoxantronecyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003068.